FULL REPORT [US$ 15 000]

INTRODUCTION [US$ 0]

• Table 2-1 SELECTED SPECIALTY EXCIPIENTS BY PRODUCT CLASS, 2002
• Table 2-2 COMMON ABBREVIATIONS AND ACRONYMS USED IN THIS REPORT

OVERVIEW OF PHARMACEUTICAL TOPICAL INDUSTRY AND EXCIPIENT FUNCTIONALITY [US$ 3 750]

• Table 3-1 SELECTED PRESCRIPTION THERAPEUTIC CLASSES WITH APPLICATION AND MEDICAL CONDITION
• Table 3-2 SELECTED NONPRESCRIPTION THERAPEUTIC CLASSES WITH APPLICATION AND MEDICAL CONDITION
• Table 3-3 MAJOR PRESCRIPTION TOPICAL PRODUCTS BY CLASS, COMPANY, AND BRAND, 2001
• Table 3-4 NONPRESCRIPTION TOPICAL PRODUCTS BY COMPANY AND BRAND, 2001
• Table 3-5 MAJOR MARKETERS OF PHARMACEUTICAL TOPICAL PRODUCTS FOR PRESCRIPTION, NONPRESCRIPTION, AND GENERIC/PRIVATE LABEL, 2001

SPECIALTY DELIVERY SYSTEMS [US$ 525]

RHEOLOGY CONTROL AGENTS [US$ 1 500]

• Table 5-1 SELECTED SPECIALTY RHEOLOGY CONTROL AGENTS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002
• Table 5-2 ESTIMATED U.S. CONSUMPTION OF RHEOLOGY CONTROL AGENTS IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002
• Table 5-3 FORECAST U.S. CONSUMPTION OF RHEOLOGY CONTROL AGENTS FOR PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002 TO 2007
• Table 5-4 SUPPLIERS AND TRADE NAMES FOR CARBOMERS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

SPECIALTY EMOLLIENTS [US$ 2 250]

NATURAL OILS [US$ 800]

• Table 6A-1 SUPPLIERS AND TRADE NAMES FOR SELECTED NATURAL OIL EMOLLIENTS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

EMOLLIENT ESTERS [US$ 800]

• Table 6B-1 SUPPLIERS AND TRADE NAMES FOR SELECTED CLASSIC EMOLLIENT ESTERS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

SPECIALTY POLYMERS [US$ 1 500]

PSEUDO COMMODITIES [US$ 3 750]

• Table 8-1 SELECTED PSEUDO COMMODITIES USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002
• Table 8-2 VOLUME AND VALUE OF SELECTED PSEUDO COMMODITIES USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002
• Table 8-3 U.S. SUPPLIERS OF PSEUDO COMMODITIES USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002
• Table 8-4 ESTIMATED SUPPLIER SALES OF PSEUDO COMMODITIES USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002
• Table 8-5 ESTIMATED SUPPLIER SALES OF PSEUDO COMMODITIES USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

POLYOLS [US$ 575]

STEARIC ACID [US$ 575]

FATTY ALCOHOLS [US$ 575]

• Table 8C-1 SUPPLIERS AND TRADE NAMES FOR SELECTED FATTY ALCOHOLS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

FATTY ALCOHOL ETHERS [US$ 575]

• Table 8D-1 SUPPLIERS AND TRADE NAMES FOR SELECTED FATTY ALCOHOL ETHERS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

SURFACTANTS [US$ 575]

• Table 8E-1 SUPPLIERS AND TRADE NAMES FOR SELECTED SURFACTANTS USED IN PHARMACEUTICAL TOPICAL DOSAGE FORMS, 2002

WAXES [US$ 575]

PROCUREMENT PRACTICES [US$ 2 250]

• Table 9-1 SELECTED CRITERIA RELATING TO SELECTION OF A SPECIALTY EXCIPIENT, 2001

REGULATORY ISSUES [US$ 525]

STEP 2 of 3

All fields in *BOLD are required.

STEP 3 of 3

*Please view our terms and conditions, and check this box to indicate your acceptance of these terms and conditions.

Thank you for your interest in subscribing to our syndicated reports. To complete this process, please click on the button below and a member of our global sales team will contact you shortly to confirm the final price and complete the transaction. Upon acceptance of your order, we will deliver the files in PDF format via email.